Copeland Capital Management LLC Buys 34,560 Shares of United States Lime & Minerals, Inc. $USLM

Copeland Capital Management LLC increased its stake in United States Lime & Minerals, Inc. (NASDAQ:USLM) by 22.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,956 shares of the construction company’s stock after purchasing an additional 34,560 shares during the period. Copeland Capital Management LLC owned approximately 0.65% of United States Lime & Minerals worth $22,266,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. JPMorgan Chase & Co. grew its position in United States Lime & Minerals by 58.5% during the third quarter. JPMorgan Chase & Co. now owns 43,964 shares of the construction company’s stock valued at $5,783,000 after acquiring an additional 16,223 shares during the last quarter. Vanguard Group Inc. grew its position in United States Lime & Minerals by 4.7% during the third quarter. Vanguard Group Inc. now owns 868,196 shares of the construction company’s stock valued at $114,211,000 after acquiring an additional 38,765 shares during the last quarter. ArrowMark Colorado Holdings LLC bought a new position in United States Lime & Minerals during the third quarter valued at approximately $26,705,000. SG Americas Securities LLC bought a new position in United States Lime & Minerals during the third quarter valued at approximately $1,093,000. Finally, TD Asset Management Inc bought a new position in United States Lime & Minerals during the third quarter valued at approximately $1,440,000. 27.12% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of United States Lime & Minerals from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, March 9th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy”.

United States Lime & Minerals Stock Performance

Shares of United States Lime & Minerals stock opened at $132.37 on Friday. United States Lime & Minerals, Inc. has a 52-week low of $89.16 and a 52-week high of $141.43. The stock has a market capitalization of $3.80 billion, a price-to-earnings ratio of 28.34 and a beta of 0.92. The company’s 50 day moving average price is $123.74 and its 200-day moving average price is $123.45.

United States Lime & Minerals (NASDAQ:USLM) last issued its earnings results on Monday, February 2nd. The construction company reported $1.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.13 by ($0.07). United States Lime & Minerals had a return on equity of 23.07% and a net margin of 36.03%.The firm had revenue of $87.94 million during the quarter, compared to the consensus estimate of $97.00 million.

United States Lime & Minerals Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Friday, February 20th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, February 20th. This represents a $0.24 dividend on an annualized basis and a yield of 0.2%. United States Lime & Minerals’s dividend payout ratio (DPR) is presently 5.14%.

About United States Lime & Minerals

United States Lime & Minerals, Inc (NASDAQ:USLM) is a producer and supplier of lime and limestone products in the United States. The company operates quarries and processing facilities across the country, specializing in the extraction and production of quicklime, hydrated lime, limestone aggregates and dolomite for use in steel manufacturing, construction, environmental remediation, agriculture and other industrial applications.

With a network of quarries concentrated in Florida and additional mining and distribution sites in other states, United States Lime & Minerals combines kiln operations and grinding plants to offer a comprehensive range of calcium‐ and magnesium‐based products.